S. Teruya

发表

Differences in blood volume components between hyporesponders and responders to erythropoietin alfa: the heart failure with preserved ejection fraction (HFPEF) anemia trial.

M. Maurer, Stephen Helmke, Sergio Teruya, 2013, Journal of cardiac failure.

Analysis of lumbar spine stenosis specimens for identification of amyloid

A. Einstein, M. Maurer, W. Blaner, 2022, Journal of the American Geriatrics Society.

Hip and knee arthroplasty are common among patients with transthyretin cardiac amyloidosis, occurring years before cardiac amyloid diagnosis: can we identify affected patients earlier?

M. Maurer, M. Weidenbaum, R. Lehman, 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

The myocardial contraction fraction is superior to ejection fraction in predicting survival in patients with AL cardiac amyloidosis

M. Maurer, Stephen Helmke, Sergio Teruya, 2015, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Impact of epoetin alfa on left ventricular structure, function, and pressure volume relations as assessed by cardiac magnetic resonance: the heart failure preserved ejection fraction (HFPEF) anemia trial.

M. Prince, M. Maurer, Stephen Helmke, 2013, Congestive heart failure.

Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection Fraction With Epoetin Alfa: Single-blind Randomized Clinical Trial of Safety and Efficacy

B. Chakraborty, D. Mancini, M. Maurer, 2013, Circulation. Heart failure.

Efficacy Fraction With Epoetin Alfa : Single-blind Randomized Clinical Trial of Safety and Treating Anemia in Older Adults With Heart Failure With a Preserved Ejection

Donna, B. Chakraborty, M. Maurer, 2013 .

IMPACT OF EPOETIN ALFA ON LV STRUCTURE, FUNCTION, AND PRESSURE-VOLUME RELATIONS AS ASSESSED BY CARDIAC MAGNETIC RESONANCE – THE HEART FAILURE PRESERVED EJECTION FRACTION (HFPEF) ANEMIA TRIAL

J. Weinsaft, M. Maurer, Stephen Helmke, 2012 .

Blood volume measurements in patients with heart failure and a preserved ejection fraction: implications for diagnosing anemia.

M. Maurer, Say Salomon, Stephen Helmke, 2011, Congestive heart failure.

Markers of nutritional status and inflammation in transthyretin cardiac amyloidosis: association with outcomes and the clinical phenotype

J. Goldsmith, M. Maurer, E. Driggin, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

A dosing algorithm for erythropoietin alpha in older adults with heart failure and a preserved ejection fraction.

M. Maurer, Stephen Helmke, A. Altincatal, 2013, Cardiovascular therapeutics.

Peak cardiac power measured noninvasively with a bioreactance technique is a predictor of adverse outcomes in patients with advanced heart failure.

D. Burkhoff, D. Mancini, M. Maurer, 2010, Congestive heart failure.

Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction

J. Goldsmith, M. Maurer, Julissa Alvarez, 2014, Journal of geriatric cardiology : JGC.

United network for organ sharing outcomes after heart transplantation for al compared to ATTR cardiac amyloidosis

G. Sayer, N. Uriel, J. Goldsmith, 2020, Clinical transplantation.

Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis

M. Maurer, R. Cheng, W. Levy, 2020, JACC. CardioOncology.

FACILITATING CLINICAL TRIALS OF ANEMIA IN OLDER ADULTS: A POINT‐OF‐CARE SYSTEM TO MEASURE HEMOGLOBIN IN THE HOME AND ITS AGREEMENT WITH A HOSPITAL CORE LABORATORY

J. Teresi, M. Maurer, J. Eimicke, 2009, Journal of the American Geriatrics Society.

Clinical Perspective on P 263 Methods Study Design

B. Chakraborty, D. Mancini, M. Maurer, 2022 .

Sex Differences in the Phenotype of Transthyretin Cardiac Amyloidosis due to Val122Ile Mutation: Insights from Non-Invasive Pressure-Volume Analysis.

D. Burkhoff, M. Maurer, Stephen Helmke, 2020, Journal of cardiac failure.

Physical Performance in Black and Hispanic Outpatients With Heart Failure: The SCAN-MP Study

M. Maurer, F. Ruberg, C. Chiuzan, 2022, CJC open.

Assessing barriers to healthy eating in hospitalized older adults with heart failure: psychometric properties of two questionnaires.

N. Carlozzi, M. Maurer, W. Karmally, 2020, Journal of cardiac failure.

Geriatric Out-of-Hospital Randomized Meal Trial in Heart Failure (GOURMET-HF) Pilot Randomized Trial: Primary Results

M. Maurer, B. Gillespie, W. Karmally, 2017 .

Can a Left Ventricular Assist Device in Individuals with Advanced Systolic Heart Failure Improve or Reverse Frailty?

J. Goldsmith, M. Maurer, V. Dickson, 2017, Journal of the American Geriatrics Society.

Home-Delivered Meals Postdischarge From Heart Failure Hospitalization: The GOURMET-HF Pilot Study

M. Maurer, B. Gillespie, W. Karmally, 2018, Circulation. Heart failure.

Insufficient Calorie Intake Worsens Post-Discharge Quality of Life and Increases Readmission Burden in Heart Failure.

M. Maurer, W. Karmally, Stephen Helmke, 2020, JACC. Heart failure.

Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients

B. Cravatt, J. Kelly, Yvonne S. Eisele, 2017, Science Translational Medicine.

Poor Lower Extremity Functioning Is Associated with Modest Increased Incidence of Probable Dementia

T. Mielenz, C. Dimino, Kevin D Silverman, 2021, Geriatrics.

Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study

M. Maurer, E. Hod, F. Ruberg, 2023, PloS one.

Diagnostic performance characteristics of planar quantitative and semi-quantitative parameters of Tc^99m pyrophosphate (PYP) imaging for diagnosis of transthyretin (ATTR) cardiac amyloidosis: the SCAN-MP study

A. Einstein, M. Maurer, L. Johnson, 2023, Journal of Nuclear Cardiology.

Racial Differences in Val122Ile associated Transthyretin Cardiac Amyloidosis.

D. Burkhoff, M. Maurer, I. Olivotto, 2021, Journal of cardiac failure.

Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)

M. Maurer, J. Kelly, Aleksandra Baranczak, 2015, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Frailty is Highly Prevalent in Patients Being Considered for a Left Ventricular Assist Device and is Associated With Depression and Reduced Quality of Life

M. Maurer, V. Dickson, S. Pinney, 2016 .

Prevalence and significance of extracardiac uptake on pyrophosphate imaging in the SCAN-MP study: the first 379 cases

A. Einstein, M. Maurer, L. Johnson, 2023, Journal of Nuclear Cardiology.

Design and Rationale the SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study

A. Einstein, M. Maurer, J. Kelly, 2023, Journal of the American Heart Association.

Factors associated with changes in serum transthyretin after treatment with tafamidis and outcomes in transthyretin cardiac amyloidosis

M. Maurer, Stephen Helmke, H. Rosenblum, 2021, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Central Obesity Is Associated With an Increased Rate of Multisite Pain in Older Adults

T. Mielenz, Sergio Teruya, C. Dimino, 2022, Frontiers in Public Health.

Temporal outcomes of patients diagnosed with transthyretin cardiac amyloidosis.

Samantha Guadalupe, Jeffeny De Los Santos, Dia A. Smiley, 2024, Journal of cardiac failure.

Days alive and outside of hospital from diagnosis of transthyretin vs. light chain cardiac amyloidosis

M. Maurer, Jonah N Rubin, Julissa Alvarez, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.